Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment.
Levine
Mark
M
Molecular and Clinical Nutrition Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1372, USA. MarkL@mail.nih.gov
Espey
Michael Graham
MG
Chen
Qi
Q
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*; D016923:Cell Death / Q000187:drug effects; D048708:Cell Growth Processes / Q000187:drug effects / Q000235:genetics; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D018673:Nutrition Policy; D029363:Organic Anion Transporters, Sodium-Dependent / Q000235:genetics; D060347:Sodium-Coupled Vitamin C Transporters; D027981:Symporters / Q000235:genetics
D029363:Organic Anion Transporters, Sodium-Dependent; D060347:Sodium-Coupled Vitamin C Transporters; D027981:Symporters; D001205:Ascorbic Acid